cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Essa Pharma Inc
14 own
43 watching
Current Price
$2.79
$0.04
(1.45%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
139.77M
52-Week High
52-Week High
5.16000
52-Week Low
52-Week Low
1.40000
Average Volume
Average Volume
0.02M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization139.77M
icon52-Week High5.16000
icon52-Week Low1.40000
iconAverage Volume0.02M
iconDividend Yield--
iconP/E Ratio--
What does the Essa Pharma Inc do?
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.
Read More
How much money does Essa Pharma Inc make?
News & Events about Essa Pharma Inc.
CNW Group - News Releases
5 months ago
ESSA Pharma Announces Clinical Trial Support Agreement with Janssen to Evaluate EPI-7386 Combinations in Patients with Prostate Cancer ESSA Pharma Announces Clinical Trial Support Agreement with Janssen to Evaluate EPI-7386 Combinations in Patients with Prostate Cancer Canada NewsWire SOUTH SAN...
PR Newswire
5 months ago
ESSA Pharma Announces Clinical Trial Support Agreement with Janssen to Evaluate EPI-7386 Combinations in Patients with Prostate Cancer ESSA Pharma Announces Clinical Trial Support Agreement with Janssen to Evaluate EPI-7386 Combinations in Patients with Prostate Cancer PR Newswire SOUTH SAN...
Ticker Report
7 months ago
ESSA Pharma Inc. (NASDAQ:EPIX Get Rating) (TSX:EPI) Research analysts at Oppenheimer issued their Q1 2024 earnings per share (EPS) estimates for ESSA Pharma in a note issued to investors on Tuesday, February 7th. Oppenheimer analyst M. Breidenbach expects that the company will post ...
PR Newswire
11 months ago
Thinking about buying stock in ESSA Pharma, Meta Platforms, Nio, Quanergy Systems, or Alphabet? Thinking about buying stock in ESSA Pharma, Meta Platforms, Nio, Quanergy Systems, or Alphabet? PR Newswire NEW YORK, Oct. 28, 2022 NEW YORK, Oct. 28, 2022 /PRNewswire/ -- InvestorsObserverissues...
Zolmax
1 year ago
Woodline Partners LP increased its stake in shares of ESSA Pharma Inc. (NASDAQ:EPIX Get Rating) (TSX:EPI) by 286.6% in the 4th quarter, HoldingsChannel reports. The firm owned 684,247 shares of the companys stock after buying an additional 507,239 shares during the quarter. Woodline Partners LPs ...
Frequently Asked Questions
Frequently Asked Questions
What is Essa Pharma Inc share price today?
plus_minus_icon
Can Indians buy Essa Pharma Inc shares?
plus_minus_icon
How can I buy Essa Pharma Inc shares from India?
plus_minus_icon
Can Fractional shares of Essa Pharma Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Essa Pharma Inc stocks?
plus_minus_icon
What is today’s traded volume of Essa Pharma Inc?
plus_minus_icon
What is today’s market capitalisation of Essa Pharma Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Essa Pharma Inc?
plus_minus_icon
What percentage is Essa Pharma Inc down from its 52-Week High?
plus_minus_icon
What percentage is Essa Pharma Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$2.79
$0.04
(1.45%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc
$8.35
$0.08 (0.97 %)
JOINT CORP/THE
JOINT CORP/THE
$9.69
$0.13 (1.36 %)
INVESCO TRUST FOR INVESTMENT
INVESCO TRUST FOR INVESTMENT
$9.45
$-0.02 (-0.21 %)
BLACKROCK NEW YORK MUNI INC
BLACKROCK NEW YORK MUNI INC
$9.43
$-0.03 (-0.32 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc
$8.35
$0.08 (0.97 %)
JOINT CORP/THE
JOINT CORP/THE
$9.69
$0.13 (1.36 %)
INVESCO TRUST FOR INVESTMENT
INVESCO TRUST FOR INVESTMENT
$9.45
$-0.02 (-0.21 %)
BLACKROCK NEW YORK MUNI INC
BLACKROCK NEW YORK MUNI INC
$9.43
$-0.03 (-0.32 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00